Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Malcolm Munro

Obstetrics & Gynecology Los Angeles, CA Medical Doctor

NPI 1932268521 CMS profile 360793

4733 W Sunset Blvd, Los Angeles, CA 90027

Open in the dashboard

General payments

$609,357

267 records reported · program years 2019–2025

Research payments

$21,229

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$20

1 holding reported · through program year 2025

Through program year 2025, Malcolm Munro of Los Angeles, CA is reported in the CMS Open Payments database as having received $609,357 across 267 general payments and $21,229 in research payments paid to them. They also declared ownership or investment interests valued at $20 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $97,499 20
2024 General $164,208 20
2023 General $24,004 17
2022 General $44,088 32
2021 General $93,681 86
2020 General $73,493 40
2020 Research $21,229 8
2019 General $112,385 52
2025 Ownership $20 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Malcolm Munro
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Malcolm Munro were reported at $97,499. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Malcolm Munro Obstetrics & Gynecology median Middle half National median
2019 $112,385 $172 $62–$391 $163
2020 $73,493 $94 $36–$222 $114
2021 $93,681 $136 $42–$369 $132
2022 $44,088 $160 $50–$433 $149
2023 $24,004 $169 $56–$423 $160
2024 $164,208 $152 $50–$371 $164
2025 $97,499 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Rejoni Inc. $185,817 26 payments
  2. Daiichi Sankyo Inc. $101,347 107 payments
  3. Hologic, LLC $87,567 19 payments
  4. Pharmacosmos Therapeutics Inc. $57,134 19 payments
  5. AbbVie, Inc. $57,102 46 payments
  6. Vifor (International) Ltd. $33,204 8 payments
  7. CooperSurgical, Inc. $26,925 12 payments
  8. American Regent $20,164 4 payments
  9. Shield Therapeutics Inc $8,822 3 payments
  10. Myovant Sciences Inc. $6,291 4 payments
  11. Other $24,982 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $371,163 88 payments
  2. Honoraria $100,275 6 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,454 23 payments
  4. Travel and Lodging $52,499 96 payments
  5. Food and Beverage $3,965 54 payments
Products named General payments · program years 2019–2025
  1. INJECTAFER Iron Deficiency Anemia $78,466 83 payments
  2. CraniSeal Dural Sealant $41,180 5 payments
  3. INJECTAFER Anemia $40,899 26 payments
  4. MONOFERRIC Hematology $39,000 1 payment
  5. ORILISSA $21,441 7 payments
  6. Monoferric Hematology $18,134 18 payments
  7. Endosee $10,000 1 payment
  8. ACCRUFER $8,822 3 payments
  9. Uterine Manipulators & Injectors $8,500 5 payments
  10. Womed Leaf $6,138 1 payment
  11. Other $15,726 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $21,229 8 payments

Records

275 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record